Location History:
- Toyoshina-machi, JP (1999)
- Nagano, JP (1997 - 2010)
Company Filing History:
Years Active: 1997-2010
Title: Innovations of Yoshinori Nonaka
Introduction
Yoshinori Nonaka is a prominent inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address abnormalities in plasma uric acid levels. With a total of 4 patents to his name, Nonaka's work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of Nonaka's latest patents is focused on a purine nucleoside derivative modified in the 8-position, which is useful for diseases associated with abnormal plasma uric acid levels. This invention provides an 8-modified purinenucleoside derivative that can be utilized for the prevention or treatment of gout, hyperuricemia, urinary lithiasis, and hyperuricemic nephropathy. The patent outlines specific chemical structures and modifications that enhance the efficacy of the compound.
Another significant patent by Nonaka involves benzimidazole derivatives that also target sodium-dependent nucleoside transporter 2. These compounds are designed to treat conditions related to abnormal plasma uric acid levels, including gout and hyperuricemia. The detailed chemical formulations and their potential medical applications highlight Nonaka's innovative approach to addressing these health issues.
Career Highlights
Yoshinori Nonaka is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work at Kissei has positioned him as a key player in the pharmaceutical industry, particularly in the area of treatments for uric acid-related diseases.
Collaborations
Nonaka collaborates with notable colleagues such as Norihiko Kikuchi and Kazuya Tatani. Their combined expertise contributes to the innovative research and development efforts at Kissei Pharmaceutical Co., Ltd.
Conclusion
Yoshinori Nonaka's contributions to pharmaceutical innovations, particularly in the treatment of uric acid-related conditions, demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of chemistry and its applications in healthcare.